SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SG who wrote (1434)3/16/2000 10:58:00 PM
From: Bob Schommer  Read Replies (2) of 1501
 
SG:

Re Crohn's disease and your son's situation, don't know if you follow ISIS pharmaceuticals; they had an unfortunate mis-cue with a promising late trial Crohn's drug, which took the starch out of the stock. They have a great patent library of antisense compounds and have picked themselves up since then. I have long held out hope for the anti-sense approach since I started following it around 93'. Hopefully IZP will fare better with their inflammatory bowel disease offering.

Regards,
Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News